source
- Biopharma capacity crunch shifts focus to ready-now manufacturing hubs like Middlesex County, NJDemand for biopharma manufacturing, especially cell and gene therapies, is growing faster than the ability to build new GMP-ready facilities, which can take years to complete. To keep pace, compan…
- Experts call for licensing framework as Utah pauses AI chatbot prescription programAlon Bergman, an assistant professor of medical ethics at the University of Pennsylvania, argues that AI-driven medical tools need a licensing system. He points to Utah’s recent pilot with the AI c…